Chronicled is a technology company.
Chronicled has raised $27.0M across 3 funding rounds.
Key people at Chronicled.
Chronicled was founded by Ryan Orr (Co-Founder & CEO).
Chronicled has raised $27.0M in total across 3 funding rounds.
Key people at Chronicled.
Chronicled was founded by Ryan Orr (Co-Founder & CEO).
Chronicled has raised $27.0M in total across 3 funding rounds.
Chronicled's investors include True Global Ventures, Streamlined Ventures.
Chronicled is a San Francisco-based technology company founded in 2014 that builds blockchain-powered solutions for the life sciences industry, primarily serving pharmaceutical manufacturers, distributors, group purchasing organizations (GPOs), and health systems.[1][2][3] Its core product, the MediLedger Network, automates trust, data alignment, and transaction settlement—such as chargebacks, rebates, and contracts—eliminating manual processes, revenue leakage, and cash flow delays in a $500 billion U.S. pharmaceutical dispensing market.[1][3][4] With 47-49 employees, $30.4 million in total funding (including an $8.3 million round), and $12.4 million in revenue, Chronicled demonstrates steady growth through industry adoption by players like Johnson & Johnson, FFF Enterprises, and Premier Inc.[1][2][7]
Chronicled was founded in 2014 in San Francisco with the initial goal of building an enterprise blockchain platform, exploring applications across multiple industries.[3] By late 2016, the company pivoted to focus on life sciences opportunities, leveraging its dual expertise in blockchain and pharma supply chains to address complexities like regulatory requirements, pricing contracts, and exceptions in drug distribution.[3][4] Key milestones include developing the industry-led MediLedger Network for transaction settlement and appointing Vinod Lakhani as CEO in April 2023, signaling leadership continuity amid expansion.[2] This evolution from broad blockchain experimentation to specialized pharma automation reflects early traction in solving real-world inefficiencies.[1][3]
Chronicled rides the blockchain-for-enterprise wave, specifically targeting life sciences' trillion-dollar supply chain challenges amid rising demands for transparency, compliance (e.g., Drug Supply Chain Security Act), and automation post-COVID disruptions.[1][3][6] Timing aligns with pharma's shift to digital ecosystems, where manual chargebacks and rebates cause leakage in a $500 billion market; blockchain's immutability counters fraud and exceptions, enabling network effects for collaborative innovation.[1][4] It influences the ecosystem by custodianship of MediLedger, sparking developer-customer partnerships to build unforeseen solutions, positioning it as a pioneer in secure, interoperable pharma transactions.[3][5]
Chronicled is poised to expand MediLedger into a full innovation platform, potentially incorporating AI for predictive pricing or broader supply chain tracking, fueled by its $30M+ funding and CEO leadership.[2][3] Trends like regulatory pressures for traceability and Web3 adoption in healthcare will accelerate growth, evolving its role from transaction settler to ecosystem enabler amid pharma digitization. As blockchain matures in regulated sectors, Chronicled's head start could amplify its influence, delivering exponential value in an industry ripe for disruption—tying back to its mission of automating trust at scale.[3][7]
Chronicled has raised $27.0M across 3 funding rounds. Most recently, it raised $8.0M Series B in February 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2022 | $8.0M Series B | True Global Ventures | |
| Jan 1, 2019 | $16.0M Series A | Streamlined Ventures | |
| Aug 1, 2017 | $3.0M Seed | Streamlined Ventures |